Skip to main content
HR 2186 113th Congress House

VALID Compounding Act

Official title: To amend the Federal Food, Drug, and Cosmetic Act to provide for the compounding of drug products.

Introduced: May 23, 2013 Introduced by: Markey, Edward J. Democratic · Massachusetts See on congress.gov
Health Administrative law and regulatory proceduresAdministrative remediesDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulation
More subjectsShow fewer subjects
Food and Drug Administration (FDA)Government information and archivesHealth care qualityHealth personnelLicensing and registrationsManufacturingPrescription drugsRetail and wholesale tradesSmall businessUser charges and fees
Sign in to write a letter Sign in to watch
This bill died when the 113th Congress ended
It never became law before the 113th Congress (2013–2014) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 24, 2013
Referred to the Subcommittee on Health.
May 23, 2013
Referred to the House Committee on Energy and Commerce.
May 23, 2013
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action May 24, 2013

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Verifying Authority and Legality In Drug Compounding Act of 2013 or VALID Compounding Act - Amends the Federal Food, Drug, and Cosmetic Act with respect to the regulation of compounding drugs.

Requires the Secretary of Health and Human Services (HHS) to develop and maintain a list of bulk substances from which drug products may be compounded that specifies any limitation on compounding of the substance and the particular medical need that is met by placing such substance on the list. Requires the Secretary to receive and consider petitions from any person identifying a substance that should be added to or removed from the list. Sets forth requirements for such petitions. Requires the Secretary also to develop and maintain a list of drug products that should not be compounded.

Allows a pharmacy to compound drugs which are not for an identified individual patient based on the receipt of a prescription order if the pharmacy registers with the Secretary and agrees to comply with any condition of operation or limitation of activity the Secretary specifies. Sets forth information that must be included in any such registration.

Authorizes the compounding of a drug that is a copy of a commercially available drug product if: (1) the drug is on the drug shortage list with notice given to the Secretary by the pharmacy, or (2) the drug product is necessary to protect public health and well-being. Requires the pharmacy to demonstrate to the Secretary that controls will be used that are comparable to elements required for safe use for a drug subject to a risk evaluation and mitigation strategy.

Requires the Secretary to establish standards, processes, and procedures for high-risk sterile compounding.

Establishes requirements related to inspections, labeling, and adverse event reporting for compounded drugs.

Requires the Secretary to assess an annual establishment fee from compounding pharmacies and a reinspection fee for any pharmacy subject to a reinspection in a fiscal year. Sets forth a methodology for setting such fees and requires reduced fees for small businesses (pharmacies with $1 million or less in annual sales).

States that the requirements of this Act do not preempt any non-federal requirement that is in addition to, and compatible with, such requirements.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2186: VALID Compounding Act. 113th Congress. Open America. https://openamerica.io/bill/113-HR-2186/
MLA
"H.R. 2186: VALID Compounding Act." 113th Congress, 2026, Open America, https://openamerica.io/bill/113-HR-2186/.
Bluebook (legal)
H.R. 2186, 113th Cong. (2026), https://openamerica.io/bill/113-HR-2186/.
Markdown link
[H.R. 2186: VALID Compounding Act](https://openamerica.io/bill/113-HR-2186/)
Report a problem